Back to Journals » Drug Design, Development and Therapy » Volume 11

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines

Total article views   Abstract views HTML views PDF downloads Totals
8,279 Dovepress* 6,913 721+ 1,215 7,634
PubMed Central* 0 645 260 645
Totals 6,913 1,366 1,475 8,279
*Since 3 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 2 3

View citations on PubMed Central and Google Scholar